Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
12th August 2019
Cameron Optometry is an award-winning optometry practice and eyewear boutique, based in Edinburgh’s New Town. The practice is now looking to welcome a new member to our friendly team. The role is hu...Read more
01st August 2019
Encouraging news for the battle against increasing rates of short-sightedness in children Cameron Optometry is delighted to announce it now has over 50 patients using Myopia Management contact lense...Read more
30th July 2019
Sustainable, stylish, independent eyewear. Welcome to Neubau Eyewear. We have been searching for another sustainable brand to add to our range and are delighted to say Neubau ticks all the boxes. An i...Read more